Reynders McVeigh Capital Management LLC Has $19.63 Million Stock Position in Procter & Gamble Company (The) $PG

Reynders McVeigh Capital Management LLC reduced its stake in Procter & Gamble Company (The) (NYSE:PG) by 3.9% during the fourth quarter, Holdings Channel.com reports. The fund owned 136,966 shares of the company’s stock after selling 5,490 shares during the period. Reynders McVeigh Capital Management LLC’s holdings in Procter & Gamble were worth $19,629,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Maseco LLP acquired a new position in shares of Procter & Gamble in the fourth quarter worth approximately $28,000. Saranac Partners Ltd acquired a new position in shares of Procter & Gamble in the third quarter worth approximately $30,000. Corundum Trust Company INC acquired a new position in shares of Procter & Gamble in the third quarter worth approximately $32,000. Caitlin John LLC acquired a new position in shares of Procter & Gamble in the third quarter worth approximately $34,000. Finally, Marquette Asset Management LLC acquired a new position in shares of Procter & Gamble in the third quarter worth approximately $37,000. 65.77% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 12,827 shares of Procter & Gamble stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $160.31, for a total transaction of $2,056,296.37. Following the completion of the transaction, the insider owned 12,639 shares in the company, valued at approximately $2,026,158.09. The trade was a 50.37% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Gary A. Coombe sold 36,093 shares of Procter & Gamble stock in a transaction dated Thursday, February 12th. The shares were sold at an average price of $162.33, for a total value of $5,858,976.69. Following the transaction, the chief executive officer owned 34,994 shares of the company’s stock, valued at $5,680,576.02. This trade represents a 50.77% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 252,715 shares of company stock worth $40,966,904. 0.20% of the stock is currently owned by corporate insiders.

Procter & Gamble Price Performance

Shares of NYSE:PG opened at $147.44 on Monday. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.44. Procter & Gamble Company has a twelve month low of $137.62 and a twelve month high of $170.99. The stock’s 50 day moving average is $149.44 and its 200-day moving average is $148.62. The firm has a market capitalization of $343.34 billion, a price-to-earnings ratio of 21.56, a PEG ratio of 6.31 and a beta of 0.41.

Procter & Gamble (NYSE:PG) last issued its earnings results on Friday, April 24th. The company reported $1.59 earnings per share for the quarter, topping analysts’ consensus estimates of $1.56 by $0.03. Procter & Gamble had a return on equity of 32.00% and a net margin of 19.16%.The company had revenue of $21.24 billion for the quarter, compared to analyst estimates of $21.52 billion. During the same period in the prior year, the firm earned $1.54 earnings per share. Procter & Gamble’s revenue for the quarter was up 7.4% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Sell-side analysts forecast that Procter & Gamble Company will post 6.92 EPS for the current fiscal year.

Procter & Gamble Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 24th will be given a dividend of $1.0885 per share. The ex-dividend date of this dividend is Friday, April 24th. This is a positive change from Procter & Gamble’s previous quarterly dividend of $1.06. This represents a $4.35 dividend on an annualized basis and a dividend yield of 3.0%. Procter & Gamble’s payout ratio is currently 63.60%.

Analyst Ratings Changes

A number of research firms recently commented on PG. Rothschild & Co Redburn cut their price objective on Procter & Gamble from $157.00 to $155.00 and set a “neutral” rating on the stock in a research note on Monday, April 27th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $163.00 price target on shares of Procter & Gamble in a research note on Monday, April 27th. Royal Bank Of Canada dropped their price target on Procter & Gamble from $172.00 to $167.00 and set an “outperform” rating on the stock in a research note on Thursday, April 9th. Jefferies Financial Group dropped their price target on Procter & Gamble from $179.00 to $175.00 and set a “buy” rating on the stock in a research note on Monday, April 20th. Finally, The Goldman Sachs Group dropped their price target on Procter & Gamble from $159.00 to $155.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 8th. Eleven investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Procter & Gamble presently has a consensus rating of “Moderate Buy” and a consensus target price of $161.06.

About Procter & Gamble

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.